Share this:

• Our first patent application is now granted in Australia, China, USA, Israel and Norway. Application approved in Japan and Russia.

• In addition the application is pending in Brazil, Canada and Europe (including. ca. 35 countries).

• Our second application is pending in Canada, USA and Europe (including ca. 35 countries).

• The program for the coming in-vitro tests has been defined and will be initiated in December and is expected to be completed Q1 2018.

• Our stationary units have been upgraded using 6 sensors in parallel whereby different locations on the body can be examined at the same time.

Share this:

Comments are closed.